TOP TIERMARKET NEWSWIRE
News & sentiment

ALLOGENE THERAPEUTIC (ALLO) — News & AI sentiment

ALLOGENE THERAPEUTIC (ALLO) news roundup. 2 stories in the past week, 16 over 30 days. Average 30-day sentiment is 51.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $63K — net selling of $63K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 59.5/100
30d stories
16
avg sentiment 51.5/100
Insider net (90d)
$63K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

ALLO news in the last 24 hours, 7 days, 30 days and 90 days

How much ALLO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowALLO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days259.5/100ALLO headlines →
Last 30 days1651.5/100ALLO headlines →
Last 90 days3254/100ALLO headlines →

Latest stories on ALLO

4d ago
6d ago
Sep 4
Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Aug 31
Aug 31
Aug 28
Aug 23
Allogene (ALLO) Q2 2026 Earnings Call Transcript
The Motley Fool65 · bullishearnings
Aug 19
Citizens reiterates Allogene stock rating on trial progress
Investing.com Analyst Ratings56 · neutralanalyst
Aug 17
Aug 17
Aug 12
Aug 12
Aug 12
Aug 12
Aug 12
Aug 4
Jul 29
Allogene Therapeutics stock rises on FDA regulatory designations
Investing.com Markets67 · bullishproduct/pr
Jul 29
Jul 29
Open ALLO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →